Advertisement

Arteriovenous Access Type and Risk of Mortality, Hospitalization, and Sepsis Among Elderly Hemodialysis Patients: A Target Trial Emulation Approach

      Rationale & Objective

      Evidence is mixed regarding the optimal choice of the first permanent vascular access for elderly patients receiving hemodialysis (HD). Lacking data from randomized controlled trials, we used a target trial emulation approach to compare arteriovenous fistula (AVF) versus arteriovenous graft (AVG) creation among elderly patients receiving HD.

      Study Design

      Retrospective cohort study.

      Setting & Participants

      Elderly patients included in the US Renal Data System who initiated HD with a catheter and had an AVF or AVG created within 6 months of starting HD.

      Exposure

      Creation of an AVF versus an AVG as the incident arteriovenous access.

      Outcomes

      All-cause mortality, all-cause and cause-specific hospitalization, and sepsis.

      Analytical Approach

      Target trial emulation approach, high-dimensional propensity score and inverse probability of treatment weighting, and instrumental variable analysis using the proclivity of the operating physician to create a fistula as the instrumental variable.

      Results

      A total of 19,867 patients were included, with 80.1% receiving an AVF and 19.9% an AVG. In unweighted analysis, AVF creation was associated with significantly lower risks of mortality and hospitalization, especially within 6 months after vascular access creation. In inverse probability of treatment weighting analysis, AVF creation was associated with lower incidences of mortality and hospitalization within 6 months after creation (hazard ratios of 0.82 [95% CI, 0.75-0.91] and 0.82 [95% CI, 0.78-0.87] for mortality and all-cause hospitalization, respectively), but not between 6 months and 3 years after access creation. No association between AVF creation and mortality, sepsis, or all-cause, cardiovascular disease–related, or infection-related hospitalization was found in instrumental variable analyses. However, AVF creation was associated with a lower risk of access-related hospitalization not due to infection.

      Limitations

      Potential for unmeasured confounding, analyses limited to elderly patients, and absence of data on actual access use during follow-up.

      Conclusions

      Using observational data to emulate a target randomized controlled trial, the type of initial arteriovenous access created was not associated with the risks of mortality, sepsis, or all-cause, cardiovascular disease–related, or infection-related hospitalization among elderly patients who initiated HD with a catheter.

      Index Words

      To read this article in full you will need to make a payment

      Subscribe:

      Subscribe to American Journal of Kidney Diseases
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Saran R.
        • Robinson B.
        • Abbott K.C.
        • et al.
        US Renal Data System 2018 Annual Data Report: epidemiology of kidney disease in the united states.
        Am J Kidney Dis. 2019; 73: A7-A8
        • Astor B.C.
        • Eustace J.A.
        • Powe N.R.
        • Klag M.J.
        • Fink N.E.
        • Coresh J.
        Type of vascular access and survival among incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for ESRD (CHOICE) Study.
        J Am Soc Nephrol. 2005; 16: 1449-1455
        • Santoro D.
        • Benedetto F.
        • Mondello P.
        • et al.
        Vascular access for hemodialysis: current perspectives.
        Int J Nephrol Renovasc Dis. 2014; 7: 281
        • Lok C.E.
        • Foley R.
        Vascular access morbidity and mortality: trends of the last decade.
        Clin J Am Soc Nephrol. 2013; 8: 1213-1219
        • Lok C.E.
        Fistula first initiative: advantages and pitfalls.
        Clin J Am Soc Nephrol. 2007; 2: 1043-1053
        • Lok C.E.
        • Huber T.S.
        • Lee T.
        • et al.
        KDOQI Clinical Practice Guideline for Vascular Access: 2019 update.
        Am J Kidney Dis. 2020; 75: S1-S164
        • Lee T.
        • Thamer M.
        • Zhang Y.
        • Zhang Q.
        • Allon M.
        Outcomes of elderly patients after predialysis vascular access creation.
        J Am Soc Nephrol. 2015; 26: 3133-3140
        • Polkinghorne K.R.
        • McDonald S.P.
        • Atkins R.C.
        • Kerr P.G.
        Vascular access and all-cause mortality: a propensity score analysis.
        J Am Soc Nephrol. 2004; 15: 477-486
        • Brown R.S.
        • Patibandla B.K.
        • Goldfarb-Rumyantzev A.S.
        The survival benefit of “fistula first, catheter last” in hemodialysis is primarily due to patient factors.
        J Am Soc Nephrol. 2017; 28: 645-652
        • Chan M.R.
        • Sanchez R.J.
        • Young H.N.
        • Yevzlin A.S.
        Vascular access outcomes in the elderly hemodialysis population: a USRDS study.
        Semin Dial. 2007; 20: 606-610
        • DeSilva R.N.
        • Patibandla B.K.
        • Vin Y.
        • et al.
        Fistula first is not always the best strategy for the elderly.
        J Am Soc Nephrol. 2013; 24: 1297-1304
        • Ravani P.
        • Quinn R.
        • Oliver M.
        • et al.
        Examining the association between hemodialysis access type and mortality: the role of access complications.
        C J Am Soc Nephrol. 2017; 12: 955-964
        • Grubbs V.
        • Wasse H.
        • Vittinghoff E.
        • Grimes B.A.
        • Johansen K.L.
        Health status as a potential mediator of the association between hemodialysis vascular access and mortality.
        Nephrol Dial Transplant. 2014; 29: 892-898
        • Xi W.
        • Harwood L.
        • Diamant M.J.
        • et al.
        Patient attitudes towards the arteriovenous fistula: a qualitative study on vascular access decision making.
        Nephrol Dial Transplant. 2011; 26: 3302-3308
        • van der Veer S.N.
        • Haller M.C.
        • Pittens C.A.
        • et al.
        Setting priorities for optimizing vascular access decision making–an international survey of patients and clinicians.
        PLoS One. 2015; 10e0128228
        • Kosa S.D.
        • Bhola C.
        • Lok C.E.
        Hemodialysis patients’ satisfaction and perspectives on complications associated with vascular access related interventions: are we listening?.
        J Vasc Access. 2016; 17: 313-319
        • Ng L.J.
        • Chen F.
        • Pisoni R.L.
        • et al.
        Hospitalization risks related to vascular access type among incident US hemodialysis patients.
        Nephrol Dial Transplant. 2011; 26: 3659-3666
        • Dember L.M.
        • Beck G.J.
        • Allon M.
        • et al.
        Effect of clopidogrel on early failure of arteriovenous fistulas for hemodialysis: a randomized controlled trial.
        JAMA. 2008; 299: 2164-2171
        • Biuckians A.
        • Scott E.C.
        • Meier G.H.
        • Panneton J.M.
        • Glickman M.H.
        The natural history of autologous fistulas as first-time dialysis access in the KDOQI era.
        J Vasc Surg. 2008; 47: 415-421
        • Allon M.
        • Imrey P.B.
        • Cheung A.K.
        • et al.
        Relationships between clinical processes and arteriovenous fistula cannulation and maturation: a multicenter prospective cohort study.
        Am J Kidney Dis. 2018; 71: 677-689
        • Huijbregts H.J.
        • Bots M.L.
        • Wittens C.H.
        • Schrama Y.C.
        • Moll F.L.
        • Blankestijn P.J.
        Hemodialysis arteriovenous fistula patency revisited: results of a prospective, multicenter initiative.
        Clin J Am Soc Nephrol. 2008; 3: 714-719
        • Hernán M.A.
        • Robins J.M.
        Using big data to emulate a target trial when a randomized trial is not available.
        Am J Epidemiol. 2016; 183: 758-764
        • Saran R.
        • Robinson B.
        • Abbott K.C.
        • et al.
        US Renal Data System 2019 Annual Data Report: epidemiology of kidney disease in the United States.
        Am J Kidney Dis. 2020; 75: S1-S64
        • Musil C.M.
        • Warner C.B.
        • Yobas P.K.
        • Jones S.L.
        A comparison of imputation techniques for handling missing data.
        West J Nurs Res. 2002; 24: 815-829
        • Andersen P.K.
        • Gill R.D.
        Cox’s regression model for counting processes: a large sample study.
        Ann Stat. 1982; : 1100-1120
        • Therneau T.M.
        • Grambsch P.M.
        The Cox model.
        in: Modeling Survival Data: Extending the Cox Model. Springer, 2000: 39-77
        • Franklin J.M.
        • Eddings W.
        • Glynn R.J.
        • Schneeweiss S.
        Regularized regression versus the high-dimensional propensity score for confounding adjustment in secondary database analyses.
        Am J Epidemiol. 2015; 182: 651-659
        • Schneeweiss S.
        • Rassen J.A.
        • Glynn R.J.
        • Avorn J.
        • Mogun H.
        • Brookhart M.A.
        High-dimensional propensity score adjustment in studies of treatment effects using health care claims data.
        Epidemiology. 2009; 20: 512
        • Brookhart M.A.
        • Wang P.
        • Solomon D.H.
        • Schneeweiss S.
        Evaluating short-term drug effects using a physician-specific prescribing preference as an instrumental variable.
        Epidemiology. 2006; 17: 268
        • Terza J.V.
        • Basu A.
        • Rathouz P.J.
        Two-stage residual inclusion estimation: addressing endogeneity in health econometric modeling.
        J Health Econ. 2008; 27: 531-543
        • Xie Y.
        • Bowe B.
        • Yan Y.
        • Xian H.
        • Li T.
        • Al-Aly Z.
        Estimates of all cause mortality and cause specific mortality associated with proton pump inhibitors among US veterans: cohort study.
        Br Med J. 2019; 365: 1580
        • R Core Team. R
        A language and environment for statistical computing.
        R Foundation for Statistical Computing, 2013
        • Lee T.
        • Qian J.
        • Thamer M.
        • Allon M.
        Tradeoffs in vascular access selection in elderly patients initiating hemodialysis with a catheter.
        Am J Kidney Dis. 2018; 72: 509-518
      1. Lyu B, Chan MR, Yevzlin AS, Astor BC. Catheter dependence after arteriovenous fistula or graft placement among elderly patients on hemodialysis. Am J Kidney Dis. Published online February 12, 2021. https://doi.org/10.1053/j.ajkd.2020.12.019.

        • Salmela B.
        • Hartman J.
        • Peltonen S.
        • Albäck A.
        • Lassila R.
        Thrombophilia and arteriovenous fistula survival in ESRD.
        Clin J Am Soc Nephrol. 2013; 8: 962-968
        • Lilly M.P.
        • Lynch J.R.
        • Wish J.B.
        • et al.
        Prevalence of arteriovenous fistulas in incident hemodialysis patients: correlation with patient factors that may be associated with maturation failure.
        Am J Kidney Dis. 2012; 59: 541-549
        • Murea M.
        • Geary R.L.
        • Edwards M.S.
        • et al.
        A randomized pilot study comparing graft-first to fistula-first strategies in older patients with incident end-stage kidney disease: Clinical rationale and study design.
        Contemp Clin Trials Commun. 2019; 14: 100357
        • Murea M.
        • Geary R.L.
        • Houston D.K.
        • et al.
        A randomized pilot study to evaluate graft versus fistula vascular access strategy in older patients with advanced kidney disease: results of a feasibility study.
        Pilot Feasibility Stud. 2020; 6: 1-15
      2. The Arteriovenous Vascular (AV) ACCESS Trial. ClinicalTrials.gov identifier: NCT04646226.
        https://ClinicalTrials.gov/show/NCT04646226
        Date accessed: November 27, 2020
      3. Hemodialysis in the Elderly (70yrs & Older) (ELDERLY). ClinicalTrials.gov identifier: NCT03065972.
        https://ClinicalTrials.gov/show/NCT03065972
        Date accessed: September 1, 2020
        • Qian J.Z.
        • McAdams-DeMarco M.
        • Ng D.K.
        • Lau B.
        Arteriovenous fistula placement, maturation, and patency loss in older patients initiating hemodialysis.
        Am J Kidney Dis. 2020; 76: 480-489.e481
        • Qian J.
        • Lee T.
        • Thamer M.
        • Zhang Y.
        • Crews D.C.
        • Allon M.
        Racial disparities in the arteriovenous fistula care continuum in hemodialysis patients.
        Clin J Am Soc Nephrol. 2020; 15: 1796-1803